Dominion Energy case study

Background Dominion Energy is an American utility company that supplies electricity and natural gas to homes, businesses, and wholesale customers. It operates through its power delivery, power generation, and gas infrastructure business segments in 15 states serving nearly seven million customers.¹ We have been engaging with the company on its climate strategy since 2011, including […]

UN AMR meeting to tackle superbugs

Fast reading AMR is a systemic problem, often caused by the misuse or overprescription of antimicrobial medicines, particularly within livestock farming. There are growing regulatory and operational risks associated with AMR, ranging from its sale, use and efficacy, to discharge and wastewater pollution. EOS has been engaging with companies on AMR since 2017, alongside our […]

Sainsbury’s case study

Background Sainsbury’s is the UK’s second largest food retailer and we have been engaging the company since 2008. Oxfam research published in 2018 had found that supermarkets’ inaction on systemic issues within global food supply chains indicated that both companies and investors were exposed to unidentified levels of risk.1 Our engagement We raised supply chain […]

Disputes proliferate in fractious vote season

Shareholders attempting to exercise their rights found themselves frustrated this vote season as recalcitrant companies pushed back on investor escalation. Meanwhile, proxy contests increased in the US following regulatory changes, allowing shareholders to consider dissident nominees alongside the company’s preferred options, with a high-profile three-way battle at Disney. Biodiversity made a strong showing via resolutions […]

Engaging on demand-side climate solutions

Engagement with fossil fuel companies – “supply-side” engagement – has been a cornerstone of EOS’s climate change engagement over the last decade. In this time, oil and gas majors have committed to ambitious methane reduction targets, a greater consensus on coal phase-outs has been established, and at COP28 there was an unprecedented reference to transitioning […]

The value of transition planning

Shareholder votes on company climate transition plans are now a key feature of the AGM season in major markets, but the ‘say-on-climate’ is still in its infancy. As a consequence, it is complex for investors to analyse a company’s climate risks and opportunities. To tackle this challenge, EOS has developed a framework to enable all […]

Carrefour case study

Our engagement We started our engagement on biodiversity in 2022, outlining our expectations in a letter for the company to identify, assess, and measure its most material impacts and dependencies on biodiversity, including associated risks. We encouraged it to develop a strategy to address these factors and articulate a plan with milestones to deliver this. […]

Is the end in sight for animal testing?

Companies are often reluctant to disclose the extent of their involvement with animal testing. But a changing regulatory and risk backdrop, coupled with the growing advantages of alternatives, indicate that treating pharmaceutical animal testing only as an ethics-based issue is unsustainable. Some 90% of drugs that pass preclinical tests ultimately fail, and the biological differences […]

EOS at Federated Hermes wins ICGN Excellence in Stewardship Award

EOS at Federated Hermes has won the Excellence in Stewardship Award at the International Corporate Governance Network’s 2024 Achievement Awards, for its pioneering systemic engagement approach to reducing methane emissions. This work has been led by Diana Glassman with support from engagers across the EOS regional teams. EOS has engaged meaningfully on reducing operational methane […]

Public Engagement Report Q2 2024 

Fast reading Changes to regulatory regimes are removing some longstanding requirements for drugs to be tested on animals. EOS has developed a framework to help investors identify a high-quality climate transition plan. How we use insights from our fossil fuel engagements to strengthen our climate discussions with companies for demand-side solutions. Animal testing is a […]